This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Bioneer Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Journey of Inventor Han-na Kim
Introduction
Han-na Kim, located in Jeonju-si, South Korea, is an accomplished inventor with a focus on improving biotechnological applications. With a patent to his name, he has made significant strides in the field of RNA technology, which plays a crucial role in modern medicine and therapeutic applications.
Latest Patents
Han-na Kim holds a patent for a "High-efficiency nanoparticle-type double-helical oligo-RNA structure and method for preparing same." This innovative patent provides a double-stranded oligo RNA structure designed to enhance stability and cell delivery efficiency. By covalently binding a polymer compound to the double-stranded oligo RNA, Han-na Kim's invention ensures the oligo RNA remains functional while also improving its stability and permeability to cell membranes. This advancement allows for effective delivery into the cells, even at low concentrations, making it a promising tool for the treatment of cancer and infectious diseases, as well as a novel delivery system for double-stranded oligo RNA.
Career Highlights
Currently, Han-na Kim is affiliated with Bioneer Corporation, where he contributes to groundbreaking research and development initiatives. His work focuses on leveraging RNA technology to enhance medical treatments and improve health outcomes.
Collaborations
Throughout his career, Han-na Kim has collaborated with talented coworkers, including Jeiwook Chae and Boram Han. These partnerships reflect a dynamic environment driven by innovation and scientific exploration, allowing them to tackle complex challenges in biotechnology together.
Conclusion
Han-na Kim's contributions to the field of biotechnology, particularly with his innovative RNA structural patents, highlight his commitment to improving healthcare solutions. His work at Bioneer Corporation, paired with strong collaborations, positions him as a prominent figure in the advancement of biotechnological applications aimed at treating serious medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile